{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:11:40Z","timestamp":1790813500568,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are amongst the inherited neuromuscular diseases with the highest incidence. Small mutations are less common and therefore have been poorly studied in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The clinical data of 150 patients diagnosed with DMD\/BMD by genetic analysis in Hunan Children\u2019s Hospital from 2009 to 2021 were analyzed. The patients were followed up for an average of 3.42 years and their clinical characteristics were collected. Loss of ambulation (LOA) was used to evaluate the severity of disease progression. The correlation among clinical features, different variants, and glucocorticoid (GC) treatment was analyzed by Cox regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>150 different variants were detected in this study, including 21 (14%) novel mutations, 88 (58.7%) non-sense mutations, 33 (22.0%) frameshift mutations, 22 (14.7%) splicing mutations, and 7 (4.7%) missense mutations. Single-exon skipping and single- or double-exon (double\/single-exon) skipping strategies covered more than 90% of patients with small mutations. A case with frameshift mutation combined with Klinefelter\u2019s syndrome (47, XXY) and another one with missense mutation combined with epilepsy was found in our study. <jats:italic>De novo<\/jats:italic> mutations accounted for 30.0% of all patients. The mean onset age was 4.19 \u00b1 1.63 years old, and the mean diagnosed age was 5.60 \u00b1 3.13 years old. The mean age of LOA was 10.4 years old (40 cases). 60.7% of them received GC treatment at 7.0 \u00b1 2.7 years old. The main causes of complaints were muscle weakness, high creatine kinase (CK), motor retardation, and family history. The risk factors of LOA were positive family history (HR 5.52, CI 1.26\u201324.18), short GC treatment duration (HR 0.54, CI 0.36\u20130.82) and frameshift mutation (HR 14.58, CI 1.74\u2013121.76). DMD patients who treated with GC after 7 years old had a higher risk of earlier LOA compared to those receiving treatment before the age of 7 (HR 0.083, CI 0.009\u20130.804). Moreover, an earlier onset age, a higher CK value, and a larger LOA population were found in the DMD patients compared to the BMD ones. Finally, the locations of the most frequent mutation were in exon 70 and exon 22.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, 150 small mutations were identified in this study, and 21 of them were discovered for the first time. We found the hotspots of small mutations were in exon 70 and exon 20. Also, the analysis showed that positive family history, frameshift mutation, short duration of GC treatment, and delayed GC treatment resulted in earlier LOA for the DMD patients. Taken together, our findings complement the mutation spectrum of DMD\/BMD, benefit us understanding to the DMD disease, and lay foundations for the clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2022.992546","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T07:16:56Z","timestamp":1667805416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and genetic characteristics of Chinese Duchenne\/Becker muscular dystrophy patients with small mutations"],"prefix":"10.3389","volume":"16","author":[{"given":"Siyi","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JND-180306","article-title":"Diagnostic accuracy of phenotype classification in Duchenne and Becker muscular dystrophy using medical record data.","volume":"5","author":"Andrews","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1212\/WNL.0000000000002891","article-title":"DMD genotypes and loss of ambulation in the CINRG Duchenne natural history study.","volume":"87","author":"Bello","year":"2016","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy.","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41434-020-0156-6","article-title":"Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.","volume":"27","author":"Dzierlega","year":"2020","journal-title":"Gene Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/sj.ejhg.5200535","article-title":"Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family.","volume":"8","author":"Ginjaar","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135189","article-title":"DMD mutations in 576 dystrophinopathy families: A step forward in genotype-phenotype correlations.","volume":"10","author":"Juan-Mateu","year":"2015","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059916","article-title":"Interplay between DMD point mutations and splicing signals in Dystrophinopathy phenotypes.","volume":"8","author":"Juan-Mateu","year":"2013","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.nmd.2017.05.019","article-title":"Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.","volume":"27","author":"Kim","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JND-170280","article-title":"Clinical outcomes in Duchenne muscular dystrophy: A study of 5345 patients from the TREAT-NMD DMD global database.","volume":"4","author":"Koeks","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-019-0873-0","article-title":"Genetic analysis of 1051 Chinese families with Duchenne\/Becker muscular dystrophy.","volume":"20","author":"Kong","year":"2019","journal-title":"BMC Med. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pedneo.2017.02.004","article-title":"The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.","volume":"59","author":"Liang","year":"2018","journal-title":"Pediatr. Neonatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/14712598.2017.1271872","article-title":"Exon skipping: A first in class strategy for Duchenne muscular dystrophy.","volume":"17","author":"Niks","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00439-019-02107-4","article-title":"Exon skipping induced by nonsense\/frameshift mutations in DMD gene results in Becker muscular dystrophy.","volume":"139","author":"Okubo","year":"2020","journal-title":"Hum. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s00415-022-11040-y","article-title":"Epileptic disorders in Becker and Duchenne muscular dystrophies: A systematic review and meta-analysis.","volume":"269","author":"Pascual-Morena","year":"2022","journal-title":"J. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/adc.69.4.453","article-title":"Occurrence of Duchenne dystrophy in Klinefelter\u2019s syndrome.","volume":"69","author":"Ramesh","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.138508","article-title":"Duchenne\/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India.","volume":"17","author":"Rao","year":"2014","journal-title":"Ann. Indian Acad. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/(sici)1097-4598(199806)21:6<792::aid-mus12>3.0.co;2-v","article-title":"Dystrophinopathy in a young boy with Klinefelter\u2019s syndrome.","volume":"21","author":"Santoro","year":"1998","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.36468\/pharmaceutical-sciences.898","article-title":"Steroid versus non-steroid regimen in treating Duchenne muscular dystrophy: An observational study from South India.","volume":"84","author":"Sattenapalli","year":"2022","journal-title":"Ind. J. Pharmaceut. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/jmg.26.4.251","article-title":"Becker muscular dystrophy (BMD) and Klinefelter\u2019s syndrome: A possible cause of variable expression of BMD within a pedigree.","volume":"26","author":"Suthers","year":"1989","journal-title":"J. Med. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mus.27532","article-title":"Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015.","volume":"66","author":"Thomas","year":"2022","journal-title":"Muscle Nerve"},{"key":"B21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.18621\/eurj.944842","article-title":"A rare missense Duchenne muscular dystrophy gene variant in a family with muscular dystrophy from Turkey.","volume":"8","author":"Tokg\u00fcn","year":"2022","journal-title":"Eur. Res. J."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237803","article-title":"The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene.","volume":"15","author":"Torella","year":"2020","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/humu.20976","article-title":"Genotype\u2013phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD\u2013DMD database: A model of nationwide knowledgebase.","volume":"30","author":"Tuffery-Giraud","year":"2009","journal-title":"Hum. Mutat."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00114","article-title":"Genotypes and phenotypes of DMD small mutations in Chinese patients with dystrophinopathies.","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Genet."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.91354","article-title":"Duchenne or Becker muscular dystrophy: A clinical, genetic and immunohistochemical study in China.","volume":"59","author":"Wang","year":"2011","journal-title":"Neurol. Ind."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1362","article-title":"DMD-related muscular dystrophy in Cameroon: Clinical and genetic profiles.","volume":"8","author":"Wonkam-Tingang","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"B27","first-page":"548","article-title":"Rare combination of dystrophinopathy and Klinefelter\u2019s syndrome in one patient.","volume":"52","author":"Xu","year":"2014","journal-title":"Chin. J. Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01837-x","article-title":"Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy.","volume":"16","author":"Zhang","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13353-020-00605-0","article-title":"Small mutations in Duchenne\/Becker muscular dystrophy in 164 unrelated Polish patients.","volume":"62","author":"Zimowski","year":"2021","journal-title":"J. Appl. Genet."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.992546\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T07:16:59Z","timestamp":1667805419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.992546\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":29,"alternative-id":["10.3389\/fnins.2022.992546"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.992546","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"article-number":"992546"}}